Press "Enter" to skip to content

New patent for Rvl Pharms drug UPNEEQ

0
Copyright © DrugPatentWatch. Originally published at New patent for Rvl Pharms drug UPNEEQ

Annual Drug Patent Expirations for UPNEEQ
Annual Drug Patent Expirations for UPNEEQ

Upneeq is a drug marketed by Rvl Pharms and is included in one NDA. There are seven patents protecting this drug.

This drug has twenty-six patent family members in twenty-two countries.

The generic ingredient in UPNEEQ is oxymetazoline hydrochloride. Additional details are available on the oxymetazoline hydrochloride profile page.

For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs, contact admin@DrugPatentWatch.com or visit www.DrugPatentWatch.com

Make Better Decisions with DrugPatentWatch

Get the Daily Briefing or Try a trial

Copyright © DrugPatentWatch. Originally published at New patent for Rvl Pharms drug UPNEEQ
    Get the DrugPatentWatch Daily Briefing

    ✓ Patent Expirations and Generic Entry

    ✓ Insightful Articles & Case Studies

    ✓ Patent Litigation & Challenges

    ✓ 505(b)(2) & Biosimilars

    ✓ Industry Trends

    DrugPatentWatch - Make Better Decisions